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Introduction 
The epidemics of obesity and related non-communicable diseases remains a matter of the utmost 
concern for public health(1). While physical exercise has been shown able to provide concrete 
benefits(2,3), there is good reason to believe that it cannot fully compensate for the deleterious changes 
produced by poor diet(4). Opinions regarding optimal diet increasingly show elements of convergence, 
especially regarding the association of dietary refinement and ultra-processed foods with poorer health 
outcomes(5). Some proposed mechanisms underlying this epidemiology of junk food include the 
removal from diet of health-promoting compounds due to inadequate fruit and vegetable 
consumption(6), and the enhancement of glycemic responses by the refinement of foods(7–9). 
Consistent with the latter, ad libitum low-carbohydrate diets (<50 g / day) have been shown to produce 
weight loss(10,11) and improve cardiovascular risk profiles(12). However, some very high 
carbohydrate diets have also been shown to be compatible with population-wide optimal metabolic 
health in non-cereal agrarian populations(13–16). Likewise, the “paleolithic style” diets used to date in 
small clinical trials have achieved consensus diet-beating improvements in metabolic and 
cardiovascular-disease risk factors(17–21) despite not restricting total carbohydrate into the <50 g / day 
range. Similar short-term benefits have also been shown for “the McDougall Program” a low fat, high 
carbohydrate diet that places a strong emphasis on food quality and minimizes processed 
carbohydrates(22). This wide range of carbohydrate content for ad libitum diets that produce weight 
loss suggests that low glycemic index and minimized insulin release are not credible explanations for 
their effects, especially in light of the experimental variability in the glycemic index of foods between 
individuals and between meal contexts(23). However, one factor that these dietary regimens do have in 
common is minimal consumption of processed foods, milled flours and sugar. The present article is an 
outline of a recently proposed mechanism(24,25) that could explain the effects of food-quality upon 
weight and health, independent of overall macronutrient composition. 
 
The Gastrointestinal Microbiota and the Immune System 
The gastrointestinal microbiota has recently been cast as a central player in the etiology of many 
disease processes, including obesity(26–29). The microbiota has been found to be required for almost 
all animal models of obesity(30), and may play a role in the vagal and hypothalamic inflammation that 
accompanies leptin resistance, hyperphagia and the onset of overweight in susceptible animals(31–36). 
Microbial transplants have been shown able to transfer the phenotypes of both overweight and liver 
pathology / altered blood sugar regulation to lean germ-free mice, suggesting a potentially causal role 
of bacteria(37–39). Furthermore, levels of T regulatory immune cells have been found to drop during 
obesity, while transplant of purified Foxp3(+) T cells from lean to obese animals has produced a 
protective effect regardless of continued obesogenic diet, indicating a potential immune system 
involvement in the causal chain of obesity(40). The integrity of the intestinal barrier may also play a 
role in the development of an obese phenotype. An “aggressive microbiota” (showing increased 
encroachment through the mucus layer) found in TLR5-/- or emulsifier-fed mice produced overweight 
and colitis, which could be transferred by microbial transplant to germ-free controls(41). Similar 
increases in body weight were produced by selective knock-outs of brush border alkaline phosphatase, 
an enzyme on the intestinal lining that breaks down microbial products(42). These effects could be 
reversed by the addition of the missing enzyme to food. Such animal models suggest that the ability of 
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microbial products to traverse the gut barrier – perhaps to the immune surveillance of the gut-
associated lymphoid tissue, may be a key determinant of the development of obesity and metabolic 
issues(36,43).  
 
Microbes as Sensors of Dietary Refinement - Dental and Systemic Health  
It has long been observed that oral and systemic health are correlated, to the extent that dental 
treatments have on occasion been marketed as a means to influence cardiovascular disease risk(44). 
Prior to the advent of farming, dental caries were rare(45,46). The human oral microbiota used to be 
substantially more diverse, but with the agricultural and industrial revolutions it underwent two major 
ecosystem shifts introducing the microbes associated with periodontal disease and caries respectively, 
with flour and sugar implicated in these shifts(47). An inappropriate innate immune response to these 
microbial changes is believed to underlie periodontitis, and may also exacerbate atherosclerosis(48,49), 
while limiting the sources of processed carbohydrate in diet can produce marked improvements in 
periodontal health(50,51). The small intestinal microbiota is proximal to both the satiety-sensing vagal 
afferents believed to play a key role in energy-homeostasis(52)(35), and to the immune system hub of 
the gut-associated lymphoid tissue(53,54). Hence, pro-inflammatory microbial ecosystem changes in 
the small intestine, analogous to those reported in the mouth, and likewise produced by powdered 
carbohydrates, would be an excellent candidate mechanism to initiate obesity, metabolic syndrome and 
a wide range of systemic immune dysregulatory effects(24). Such an interaction might explain the 
adverse impacts of food processing and dietary refinement on health, and how macronutrient-diverse 
diets can apparently reverse many of these effects by removing foods that may functionally resemble a 
bacterial growth medium.  
 
Obesity as a Process of Sensitization 
It has been observed that long term weight loss after the onset of obesity is a rare exception(55).  Those 
attempting to calorically restrict Western diets appear to defend their elevated weight, indicating that 
obesity is a disruption of energy homeostasis(56). Low-carbohydrate(11), Paleolithic(57,58) and 
McDougall(22) style diets each produce ad libitum weight loss, indicating that these dietary styles 
produce a rectification of that body weight set-point, likely by restoring leptin sensitivity. It is a 
common anecdotal observation that formerly obese persons following such diets appear to remain 
sensitized to elements of the standard Western diet, and must remain adherent to their new way of 
eating or return to overweight. Indeed it is similarly observed that relief from diverse long-term 
symptoms and conditions in the non-obese achieved via such diets is also adherence-dependent. These 
observations of a 'memory' of the problems caused by elements of Western diet may be pertinent to the 
proposed microbial/immune mechanism, in that adaptive immunity is a candidate mechanism for 
persisting sensitivity to a process despite its prolonged absence. This raises the possibility that what 
precludes a return to eating refined or processed foods, even after extended adherence to a diet of 
elevated food quality, may be an immunological memory of elements of a gut microbial ecosystem 
promoted by the refined Western diet. Figure 1 shows a schematic overview of the effects of this 
proposed sensitization process to refined foods. 
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Figure 1. Overview of the proposed effects of sensitization to refined foods. The x-axis represents 
the proportion of refined foods in diet, while the y-axis depicts the resultant health outcomes.  It is 
proposed that people begin on the 'non-sensitized' curve (solid black). The arrows represent an 
increasing risk of transitioning to the 'sensitized' curve (dotted black) with exposure to higher 
proportions of refined foods in diet (this assumption has been included due to the worsening of Western 
diseases as dietary refinement has increased). Health outcomes are worse in the 'sensitized' than the 
'non-sensitized' at any level of exposure to refined foods. This is based upon the anecdotal accounts of 
those in long term remission from obesity and other Western diseases by eating ad libitum without 
refined foods, and the degree of strictness often required. It is proposed that there are likely many 
different degrees and natures of sensitization possible, which may predispose toward diverse Western 
diseases, however, here one 'sensitized' curve is shown for clarity. The approximate location of a 
Mediterranean diet is indicated. The threshold for atherosclerosis (grey line) is placed on the 
assumption that a Mediterranean diet will halt atherosclerosis in the non-sensitized. The grey box 
depicts the range of dietary refinement tested by the overwhelming majority of dietary research. 
 
Consensus dietary advice places considerable emphasis on the inclusion of breads and baked goods, 
and it is arguable that this retention of flour-derived foods may be responsible for the poor consensus 
performance versus paleolithic diets in the clinical trials carried out to date(17–21,58,59). The 
omnipresence of flour, breads and baked goods in most nutrition research has prevented the proper 
investigation of the concentration-health relationship for refined foods in 'sensitized' populations, 
which anecdotal observations from those eating no refined foods indicate may be non-linear. 
 
While overall levels of dietary fat do not appear to be strongly linked to body weight(11), it cannot be 
ruled out that for some people a sensitization to microbial changes produced by refined fats / oils may 
3
Spreadbury: Dietary Refinement and Upper Gut Microbiota
Published by Journal of Evolution and Health, 2017
develop over time and play a clinically relevant role. Perhaps this possibility of a role of 'fat quality' 
and the bio-structural context of consumed lipids should be borne in mind by those eating low 
carbohydrate / high fat diets. 
 
Summary 
The interplay between foods altered by human ingenuity and the microbial ecosystem of the upper 
gastrointestinal tract is an excellent candidate mechanism to explain the effects of human nutrition 
transitions over the last 10,000 years, and the epidemics of obesity and non-communicable disease. 
Diets with widely differing macronutrient ratios and differing core principles (low-carbohydrate(11), 
Paleolithic(57,58) and plant-based McDougall(22)) might produce their ad libitum weight loss by 
removing more refined / processed foods than achieved by the consensus Mediterranean / DASH diets. 
By removing evolutionarily novel powdered carbohydrates from the mouth and upper GI tract, these 
diets may enable a more evolutionarily consistent microbial ecosystem, allowing more accurate energy 
homeostasis and immune regulation, alongside parallel improvements to oral health. 
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